Institute of Molecular and Cell Biology
Philipp Kaldis received his PhD from the Institute for Cell Biology, ETH (Swiss Federal Institute of Technology), Zürich, Switzerland, in 1994 where he worked on the mitochondrial creatine kinase with Dr. Theo Wallimann and Dr. Hans Eppenberger. In 1995, he joined Dr. Mark Solomon’s laboratory at Yale University School of Medicine, Department of Molecular Biophysics and Biochemistry, New Haven, Connecticut, as a postdoctoral fellow/associate research scientist to investigate the activation of cyclin-dependent kinases (Cdks). In 2000, Dr. Kaldis joined the National Cancer Institute (NCI)-Frederick as tenure-track investigator and was promoted to senior investigator with tenure in 2006. In 2007, he joined the IMCB as senior principal investigator. Dr. Kaldis is the co-editor-in-chief of Cell Division (BioMedCentral/Springer) and the specialty chief editor for the section on “Cell Growth and Division” of Frontiers in Cell and Developmental Biology. He has been a member of the organizing committee of the Frontiers in Cancer Sciences conference since 2010.